Bristol-Myers Squibb
Last updated on 2015-01-03T21:55+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| specialist | 2.44% | EN | 10/10/2017 |
| rival | 26.83% | EN | 16/02/2017 |
| leader | 63.41% | EN | 31/07/2016 |
| chief executive officer | 2.44% | EN | 31/01/2012 |
| rival | 4.88% | PT | 22/03/2006 |
| Names | Lang | Count |
|---|---|---|
| Bristol-Myers Squibb | EN | 61.87% |
| Bristol-Myers Squibb | FR | 9.18% |
| Bristol Myers Squibb | EN | 4.38% |
| Bristol-Myers Squibb | PT | 2.70% |
| Bristol-Myers Squibb | ES | 2.22% |
| Bristol-Myers Squibb | DE | 2.16% |
| Bristol-Myers Squibb | IT | 2.01% |
| Bristol-Myers Squibb | PL | 2.01% |
| Bristol-Myers Squibb | HR | 1.98% |
| Bristol-Myers Squibb | SV | 1.98% |
| Bristol-Myers Squibb | EU | 1.98% |
| Bristol-Myers Squibb | ZH | 1.98% |
| Bristol Myers Squibb | FR | 0.97% |
| Bristol Myers-Squibb | EN | 0.88% |
| Bristol-Meyers Squibb | EN | 0.73% |
| Bristol Myers Squibb | ES | 0.55% |
| Bristol Myers Squibb | RO | 0.52% |
| Bristol-Meyers Squibb | FR | 0.27% |
| Bristol Meyers Squibb | EN | 0.24% |
| Bristol Myers-Squibb | DE | 0.21% |
| Bristol Myers-Squibb | FR | 0.21% |
| Bristol Myers Squibb | PT | 0.21% |
| BRISTOL-MYERS SQUIBB | FR | 0.18% |
| BRISTOL MYERS SQUIBB | FR | 0.12% |
| Bristol-Myers-Squibb | EN | 0.12% |
| Bristol-Myers-Squibb | FR | 0.09% |
| BRISTOL-Myers Squibb | FR | 0.03% |
| Bristol-Myers-Squibb | EU | 0.03% |
| Bristol Meyers Squibb | FR | 0.03% |
| Bristol Myers Squibb | DE | 0.03% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 6.33% |
| Eli Lilly | 3.52% |
| Pfizer Inc | 3.52% |
| Novartis | 2.91% |
 | Commission | 2.21% |
| Drug Administration | 1.91% |
| World Health Organization | 1.31% |
| Novo Nordisk | 1.21% |
| Boehringer Ingelheim | 1.21% |
| Risk Factors | 1.11% |
| Teva Pharmaceuticals | 1.11% |
| GlaxoSmithKline | 1.11% |
| Roche Holding AG | 1.11% |
| Pharmaceuticals Inc | 1.01% |
| Cancer Research | 1.01% |
| European Union | 1.01% |
| Reuters Group | 0.90% |
| Wall Street | 0.80% |
| SA | 0.80% |
| Sara Peerun | 0.80% |
| United Nations | 0.80% |
| Association | 0.80% |
| Solutions | 0.80% |
| Mayo Clinic | 0.70% |
| Memorial Sloan Kettering Cancer Center | 0.70% |
| Saudi | 0.70% |
| Daiichi Sankyo | 0.70% |
| Celgene Corporation | 0.60% |
| Duke university | 0.60% |
| Kyowa Hakko Kirin | 0.60% |
| Type | Entity Name | Score |
|---|---|---|
| Pfizer Inc | 0.0369 |
| Eli Lilly | 0.0352 |
| Steven Hildemann | 0.0303 |
| Novartis | 0.0274 |
| Sol Barer | 0.0215 |
| John Graziano | 0.0196 |
| Michael M Morrissey | 0.0192 |
| Gustavo Mahler | 0.0192 |
| Lee Morley | 0.0189 |
| Drug Administration | 0.017 |
| Cord Dohrmann | 0.0169 |
| Maria Monti | 0.015 |
| Boehringer Ingelheim | 0.0124 |
| Novo Nordisk | 0.0116 |
| Ron Myers | 0.0116 |
| Victor Velculescu | 0.0115 |
| Teva Pharmaceuticals | 0.0113 |
| Roche Holding AG | 0.0109 |
| Cancer Research | 0.0105 |
| GlaxoSmithKline | 0.0103 |
| Inc | 0.0101 |
| Risk Factors | 0.01 |
| Pharmaceuticals Inc | 0.0098 |
| Jonathon Maguire | 0.0088 |
| Sara Peerun | 0.008 |
| Advanced Cell Technology | 0.008 |
| Memorial Sloan Kettering Cancer Center | 0.0074 |
| Daiichi Sankyo | 0.0069 |
| Philip Astley | 0.0066 |
| Mayo Clinic | 0.0064 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Monday, January 20, 2020
12:37:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 